A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC779 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(2R)BSC779 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements P{XP}aptd01747 and PBac{WH}f02049 are 2R:19468319 ;19664298 and the cytological breakpoints predicted from these coordinates are 59F1;59F7.